CLPT Clearpoint Neuro Inc
Company Analysis
Latest News
🔴 Clearpoint Neuro is trading 6.1% down as cause remains unclear
Clearpoint Neuro is trading 6.1% lower at $9.05, and the cause of the decline remains unclear. - No company-specific announcement explaining the decline was...
🔴 Clearpoint Neuro is trading 5.5% down in after-hours trading
Clearpoint Neuro is trading 5.5% down at $9.11 in after-hours trading, and the reason for the decline remains unclear. - Shares closed at $9.64 in the October...
🔴 Clearpoint Neuro is trading 5% down today amid likely CPI-driven market pressure
Clearpoint Neuro is trading at $9.31, down 5.1%, with CPI-driven market pressure the most likely explanation. - No new company-specific announcement was...
🔴 Clearpoint Neuro is trading 5% down
Clearpoint Neuro is trading 5.25% down at $10.91, with no new company announcement explaining the October 6 decline. - The latest listed release was its...
🟢 Clearpoint Neuro is trading 5% up today amid broader market gains
Clearpoint Neuro is trading at $11.45, up 5.09%, with broader risk-on sentiment the likeliest context; no company-specific catalyst was identified. - U.S....
🟢 Clearpoint Neuro is trading 5% up in pre-market
Clearpoint Neuro is trading 5.28% up at $11.47 in pre-market on October 5, 2026, with no new company-specific announcement identified to explain the move. -...
🔴 Clearpoint Neuro is trading 5% down amid possible healthcare-sector pressure
Clearpoint Neuro is trading at $11.59, down 5.08% on October 1, 2026; no new company-specific announcement explaining the decline surfaced in the search. -...
🟢 Clearpoint Neuro is trading 6% up on September 30, 2026 with no identified catalyst
Clearpoint Neuro is trading at $12.42, up +5.53% during the September 30 session, with no specific catalyst identified. - No new Clearpoint Neuro announcement...
Clearpoint Neuro's Big Bet on Gene Therapy Delivery Takes a Hit — But Is the Selloff Overdone?
Shares of Clearpoint Neuro cratered 15.8% to $12.88 Tuesday morning after partner uniQure reported that its Huntington's disease gene therapy showed a weaker...
🔴 Clearpoint Neuro is trading 15.84% down now at $12.88 after AMT-130 missed statistical significance
Clearpoint Neuro is trading 15.84% down at $12.88 after a September 29 report linked the selloff to disappointing uniQure AMT-130 results. - The Huntington’s...
🔴 Clearpoint Neuro is trading 27.86% down in pre-market
Clearpoint Neuro is trading 27.86% down at $11.04 in pre-market, based on the supplied pre-market price, after closing at $15.31 on September 28; no reported...
🔴 Clearpoint Neuro is trading 5% down today amid rising crude oil and Treasury yields
Clearpoint Neuro is trading 5% down at $15.00 amid broader risk-off trading on September 23, 2026. - The S&P 500 was down 0.73% and Nasdaq Composite down...
Stifel Says Clearpoint Neuro Is Worth 42% More — But Can a Tiny MedTech Company Really Ride the Gene-Therapy Wave?
Stifel Doubles Down on Clearpoint Neuro at $22 — Can a $470M Company Really Capture the Gene-Therapy Delivery Market? Shares of Clearpoint Neuro surged 11.1%...
🟢 Clearpoint Neuro is trading 11.1% up today after Stifel reiterated Buy rating and $22 target
Clearpoint Neuro is trading 11.1% higher at $15.52 after Stifel reiterated its Buy rating and $22 price target, citing the company’s cell- and gene-therapy...
🟢 Clearpoint Neuro is trading 5.6% up today amid Stifel's reiterated $22 target
Clearpoint Neuro is trading at $14.75 (+5.58%), following steady gains from $13.46 on September 14 to $13.97 on September 21. - No fresh company-specific...
🟢 Clearpoint Neuro is trading 5.83% up in pre-market with no fresh company-specific announcement identified
Clearpoint Neuro is trading at $14.27, up +5.83% before September 11, 2026, with no fresh company-specific announcement identified. - S&P 500 futures are up...
🟢 Clearpoint Neuro is trading 5% up today on healthcare-sector strength
Clearpoint Neuro is trading 5.1% up at $15.66, apparently supported by healthcare-sector strength rather than a company-specific catalyst. - No fresh...
🟢 Clearpoint Neuro is trading 7.58% up in pre-market despite no new company-specific catalyst
Clearpoint Neuro is trading 7.58% up at $16.03 after no new company-specific catalyst was identified for September 2, 2026. - The latest official...
🟢 Clearpoint Neuro is trading 10.75% up today — no clear company-specific catalyst identified
Clearpoint Neuro is trading 10.75% up at $16.80, with no clear company-specific catalyst identified for August 25, 2026. - The latest listed company release...
🟢 Clearpoint Neuro is trading 6% up today
Clearpoint Neuro is trading at $16.10, up 6.13%, with no clear catalyst identified. - No new company-specific announcement dated August 25, 2026 was...